skip to main content

Gestational Trophoblastic Disease

Gestational trophoplastic disease (GTD) is a group of tumors that develop from the abnormal growth of cells inside the uterus (womb) that would normally develop into the placenta (the organ that passes nutrients from the mother to the fetus) during pregnancy.

Gynecologic Cancers Risk Factors

A risk factor is anything that changes your chance of getting a disease such as cancer. Different cancers have different risk factors. For example, exposing skin to strong sunlight is a risk factor for skin cancer. Smoking is a risk factor for many cancers. But having a risk factor, or even several, does not mean that you will get the disease.

Intensified Lung Cancer Radiation Treatment

Researchers at the University of Michigan Comprehensive Cancer Center found an innovative approach to improve control of locally advanced lung cancer tumors while preserving more normal tissue. It involves a midtreatment PET-CT scan using the radioactive tracer fluorodeoxyglucose (FDG) and then individualizing escalated radiation to the target region the tracer identifies.

Does every cancer need immediate treatment? The case for active surveillance for low-risk cancers

Michigan Medicine experts discuss whether active surveillance could reduce overtreatment for some thyroid, prostate and breast cancers

Appropriate Distress Screening and Follow Up Leads to Fewer ER Visits and Hospitalizations in Patients with Cancer, Study Finds

Following a cancer diagnosis, all patients experience some level of distress -- regardless of disease stage. When severe and left untreated, distress can have a significant impact on health outcomes, lead to greater mortality and morbidity, affect immune function, and result in higher health care expenditures.

Immunotherapy, Gene Therapy Combination Shows Promise Against Glioblastoma

New research out of the University of Michigan supports combining two approaches to fight back against gliomas: attacking the tumor with gene therapy while enhancing the immune system’s ability to fight it, too.

Researchers propose new approach to identify genetic mutations in men with prostate cancer

In a new study, researchers used a patient's own cancer history rather than family history to identify genetic mutations that might influence cancer treatment and risk for family members.

Pages